kaiyun(Öйú)¹Ù·½ÍøÕ¾-¿ªÔÆÌåÓý¹Ù·½Èë¿Ú

¡¾Âö²¬Ò½Ò©¡¿MedBio|5543-57-7|(S)-»ª·¨ÁÖ¼¼Êõ×ÊÁÏ

2021-03-04

S-ÎÄÀ­·¨ÐÁ½á¹¹Ê½

(S)-»ª·¨ÁÖÖÐÎıðÃû£º»ª·¨ÁÖSÒì¹¹ÌåÔÓÖÊ;S-ÎÄÀ­·¨ÐÁ;±¡ÑªÍè;S-(-)-»ª·¨ÁÖ;(-)-WARFARIN

 

1¡¢(S)-»ª·¨ÁÖÐÁÎïÀí»¯Ñ§ÐÔÖÊ£º

ÃÜ¶È 1.3¡À0.1 g/cm3
·Ðµã 515.2¡À50.0 ¡ãC at 760 mmHg
È۵㠡Ý170?C
·Ö×Óʽ C19H16O4
·Ö×ÓÁ¿ 308.328
ÉÁµã 188.8¡À23.6 ¡ãC
¾«È·ÖÊÁ¿ 308.104858
PSA 67.51000
LogP 3.42
Íâ¹ÛÐÔ×´ white to pale yellow
ÕôÆûѹ 0.0¡À1.4 mmHg at 25¡ãC
ÕÛÉäÂÊ 1.635
´¢´æÌõ¼þ

2-8¡æ ±Ü¹â£¬ÒõÁ¹¸ÉÔï´¦£¬ÃÜ·â±£´æ

Îȶ¨ÐÔ

³£Î³£Ñ¹ÏÂÎȶ¨

·Ö×ӽṹ

1¡¢ Ħ¶ûÕÛÉäÂÊ£º84.44

2¡¢ Ħ¶ûÌå»ý£¨m3/mol£©£º235.7

3¡¢ µÈÕűÈÈÝ£¨90.2K£©£º652.4

4¡¢ ±íÃæÕÅÁ¦£¨dyne/cm£©£º58.6

5¡¢ ¼«»¯ÂÊ£¨10 -24cm 3£©£º33.47

¼ÆË㻯ѧ

1¡¢ ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©£º2.7

2¡¢ Çâ¼ü¹©ÌåÊýÁ¿£º1

3¡¢ Çâ¼üÊÜÌåÊýÁ¿£º4

4¡¢ ¿ÉÐýת»¯Ñ§¼üÊýÁ¿£º4

5¡¢ »¥±äÒì¹¹ÌåÊýÁ¿£º

6¡¢ ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý£¨TPSA£©£º63.6

7¡¢ ÖØÔ­×ÓÊýÁ¿£º23

8¡¢ ±íÃæµçºÉ£º0

9¡¢ ¸´ÔÓ¶È£º502

10¡¢ Í¬Î»ËØÔ­×ÓÊýÁ¿£º0

11¡¢ È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

12¡¢ ²»È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º1

13¡¢ È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

14¡¢ ²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

15¡¢ ¹²¼Û¼üµ¥ÔªÊýÁ¿£º1

 

2¡¢(S)-»ª·¨ÁÖÉú̬ѧÊý¾Ý£º

¸ÃÎïÖʶԻ·¾³¿ÉÄÜÓÐΣº¦£¬¶ÔË®ÌåÓ¦¸øÓèÌØ±ð×¢Òâ¡£

3¡¢(S)-»ª·¨ÁÖÐÔÖÊÓëÎȶ¨ÐÔ£º

³£Î³£Ñ¹ÏÂÎȶ¨¡£

4¡¢(S)-»ª·¨ÁÖ·Ö×ӽṹÊý¾Ý£º

£¨1£©Ä¦¶ûÕÛÉäÂÊ£º84.44

£¨2£© Ä¦¶ûÌå»ý£¨m3/mol£©£º235.7

£¨3£© µÈÕűÈÈÝ£¨90.2K£©£º652.4

£¨4£©±íÃæÕÅÁ¦£¨dyne/cm£©£º58.6

£¨5£©¼«»¯ÂÊ£¨10-24cm3£©£º33.47

5¡¢(S)-»ª·¨ÁÖÖü´æ·½·¨£º

2-8¡æ ±Ü¹â£¬ÒõÁ¹¸ÉÔï´¦£¬ÃÜ·â±£´æ

6¡¢(S)-»ª·¨ÁÖÓÃ;£º

(S)-Warfarin is a more potent enantiomer of Warfarin as a vitamin K antagonist, anticoagulant.

7¡¢(S)-»ª·¨Áֲο¼ÎÄÏ×£º

Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes.

J. Thromb. Haemost. 8(12) , 2708-17, (2010)

Secreted protein profile from HepG2 cells incubated by S(-) and R(+) enantiomers of chiral drug warfarin - An analysis in cell-based system and clinical samples.

Proteomics. Clin. Appl. 4(10-11) , 808-15, (2010)

Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.

Hum. Gene Ther. 20(9) , 975-88, (2009)

8¡¢(S)-»ª·¨ÁÖÓ¢ÎıðÃû£º

S-(?)-4-Hydroxy-3-(3-oxo-1-phenybutyl)-2H-1-benzopyran-2-one
ATHROMBIN
4-Hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-chromen-2-one
(-)-Warfarin
(S)-Warfarin
MFCD00272381
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, (S)-
Varfine
Tintorane
3-a-Phenyl-b-acetylethyl-4-hydroxycoumarin
2H-1-Benzopyran-2-one, 4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-
Warfarin
(¡À)-Warfarin
(RS)-Warfarin
Warfilone
Warcoumin
3-(¦Á-acetonylbenzyl)-4-hydroxycoumarin
3-(¦Á-Phenyl-¦Â-acetylethyl)-4-hydroxycoumarin
RODEX
3-(a-acetonylbenzyl)-4-hydroxycoumarin
4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one
Warfarin,R
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
Antrombin K
Coumadin
Athrombin-K
(S)-(-)-Warfarin
Warfarin K
EINECS 226-907-3
»õºÅ ²úÆ·Ãû³Æ Æ·ÅÆ ¹æ¸ñÐͺаü×° Ŀ¼¼Û ÊýÁ¿ ¹ºÎï³µ
MED80009 (S)-»ª·¨ÁÖ ,5543-57-7 MedBio ¡Ý98% 5mg ?3205.00
MED80009 (S)-»ª·¨ÁÖ ,5543-57-7 MedBio ¡Ý98% 25mg ?11655.00
MED80009 (S)-»ª·¨ÁÖ ,5543-57-7 MedBio ¡Ý98% 1mg ?1025.00
MED80009 (S)-»ª·¨ÁÖ ,5543-57-7 MedBio ¡Ý98% 10mg ?5594.00
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿